{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T21:58:34Z","timestamp":1787522314591,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:00:00Z","timestamp":1703289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:00:00Z","timestamp":1703289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10557-023-07540-2","type":"journal-article","created":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:02:05Z","timestamp":1703289725000},"page":"491-498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["MOTS-c Peptide Attenuated Diabetic Cardiomyopathy in STZ-Induced Type 1 Diabetic Mouse Model"],"prefix":"10.1007","volume":"39","author":[{"given":"Nan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caijie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0347-4514","authenticated-orcid":false,"given":"Peng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,23]]},"reference":[{"issue":"11","key":"7540_CR1","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.2337\/db10-1333","volume":"60","author":"Y Li","year":"2011","unstructured":"Li Y, Ma J, Zhu H, et al. Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes. Diabetes. 2011;60(11):2985\u201394. https:\/\/doi.org\/10.2337\/db10-1333.","journal-title":"Diabetes"},{"issue":"6","key":"7540_CR2","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.2337\/db10-0351","volume":"60","author":"Z Xie","year":"2011","unstructured":"Xie Z, Lau K, Eby B, et al. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes. 2011;60(6):1770\u20138. https:\/\/doi.org\/10.2337\/db10-0351.","journal-title":"Diabetes."},{"issue":"16","key":"7540_CR3","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1161\/circulationaha.118.033552","volume":"139","author":"S Wu","year":"2019","unstructured":"Wu S, Lu Q, Ding Y, et al. Hyperglycemia-driven inhibition of AMP-activated protein kinase \u03b12 induces diabetic cardiomyopathy by promoting mitochondria-associated endoplasmic reticulum membranes in vivo. Circulation. 2019;139(16):1913\u201336. https:\/\/doi.org\/10.1161\/circulationaha.118.033552.","journal-title":"Circulation"},{"issue":"1","key":"7540_CR4","doi-asserted-by":"publisher","first-page":"20077","DOI":"10.1038\/s41598-021-99568-3","volume":"11","author":"J Yuan","year":"2021","unstructured":"Yuan J, Wang M, Pan Y, et al. The mitochondrial signaling peptide MOTS-c improves myocardial performance during exercise training in rats. Sci Rep. 2021;11(1):20077. https:\/\/doi.org\/10.1038\/s41598-021-99568-3.","journal-title":"Sci Rep"},{"issue":"1","key":"7540_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s12012-021-09706-6","volume":"22","author":"P Zhong","year":"2022","unstructured":"Zhong P, Peng J, Liu T, Ding HS. AAV9-mediated cardiac CNTF overexpression exacerbated adverse cardiac remodeling in streptozotocin-induced type 1 diabetic models. Cardiovasc Toxicol. 2022;22(1):88\u201396. https:\/\/doi.org\/10.1007\/s12012-021-09706-6.","journal-title":"Cardiovasc Toxicol"},{"key":"7540_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bbrc.2021.01.111","volume":"547","author":"P Zhong","year":"2021","unstructured":"Zhong P, Zeng G, Lei C, et al. Ciliary neurotrophic factor overexpression protects the heart against pathological remodelling in angiotensin II-infused mice. Biochem Biophys Res Commun. 2021;547:15\u201322. https:\/\/doi.org\/10.1016\/j.bbrc.2021.01.111.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"7540_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cmet.2015.02.009","volume":"21","author":"C Lee","year":"2015","unstructured":"Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443\u201354. https:\/\/doi.org\/10.1016\/j.cmet.2015.02.009.","journal-title":"Cell Metab"},{"key":"7540_CR8","doi-asserted-by":"publisher","unstructured":"Grubi\u0107 Rotkvi\u0107 P, Planini\u0107 Z, Liberati Pr\u0161o AM, et al. The mystery of diabetic cardiomyopathy: from early concepts and underlying mechanisms to novel therapeutic possibilities. Int J Mol Sci. 2021;22(11). https:\/\/doi.org\/10.3390\/ijms22115973.","DOI":"10.3390\/ijms22115973"},{"key":"7540_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.freeradbiomed.2016.05.015","volume":"100","author":"C Lee","year":"2016","unstructured":"Lee C, Kim KH, Cohen P. MOTS-c: a novel mitochondrial-derived peptide regulating muscle and fat metabolism. Free Radic Biol Med. 2016;100:182\u20137. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.05.015.","journal-title":"Free Radic Biol Med"},{"key":"7540_CR10","doi-asserted-by":"publisher","first-page":"104381","DOI":"10.1016\/j.phrs.2019.104381","volume":"147","author":"Z Yan","year":"2019","unstructured":"Yan Z, Zhu S, Wang H, et al. MOTS-c inhibits osteolysis in the mouse calvaria by affecting osteocyte-osteoclast crosstalk and inhibiting inflammation. Pharmacol Res. 2019;147:104381. https:\/\/doi.org\/10.1016\/j.phrs.2019.104381.","journal-title":"Pharmacol Res"},{"key":"7540_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.molimm.2017.10.017","volume":"92","author":"D Zhai","year":"2017","unstructured":"Zhai D, Ye Z, Jiang Y, et al. MOTS-c peptide increases survival and decreases bacterial load in mice infected with MRSA. Mol Immunol. 2017;92:151\u201360. https:\/\/doi.org\/10.1016\/j.molimm.2017.10.017.","journal-title":"Mol Immunol"},{"key":"7540_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijcard.2018.03.031","volume":"268","author":"H Li","year":"2018","unstructured":"Li H, Ren K, Jiang T, Zhao GJ. MOTS-c attenuates endothelial dysfunction via suppressing the MAPK\/NF-\u03baB pathway. Int J Cardiol. 2018;268:40. https:\/\/doi.org\/10.1016\/j.ijcard.2018.03.031.","journal-title":"Int J Cardiol"},{"key":"7540_CR13","doi-asserted-by":"publisher","unstructured":"Shen C, Wang J, Feng M, et al. The mitochondrial-derived peptide MOTS-c attenuates oxidative stress injury and the inflammatory response of H9c2 cells through the Nrf2\/ARE and NF-\u03baB pathways. Cardiovasc Eng Technol. 2021. https:\/\/doi.org\/10.1007\/s13239-021-00589-w.","DOI":"10.1007\/s13239-021-00589-w"},{"issue":"12","key":"7540_CR14","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/j.bbadis.2016.07.001","volume":"1862","author":"SC Bairwa","year":"2016","unstructured":"Bairwa SC, Parajuli N, Dyck JR. The role of AMPK in cardiomyocyte health and survival. Biochim Biophys Acta. 2016;1862(12):2199\u2013210. https:\/\/doi.org\/10.1016\/j.bbadis.2016.07.001.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"7540_CR15","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.tem.2020.07.001","volume":"31","author":"X Wang","year":"2020","unstructured":"Wang X, Wang Y, Antony V, Sun H, Liang G. Metabolism-associated molecular patterns (MAMPs). Trends Endocrinol Metab. 2020;31(10):712\u201324. https:\/\/doi.org\/10.1016\/j.tem.2020.07.001.","journal-title":"Trends Endocrinol Metab"},{"issue":"11","key":"7540_CR16","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.2337\/db08-0564","volume":"57","author":"MR Dasu","year":"2008","unstructured":"Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes. 2008;57(11):3090\u20138. https:\/\/doi.org\/10.2337\/db08-0564.","journal-title":"Diabetes"},{"issue":"5","key":"7540_CR17","doi-asserted-by":"publisher","first-page":"e97985","DOI":"10.1371\/journal.pone.0097985","volume":"9","author":"J Ma","year":"2014","unstructured":"Ma J, Chadban SJ, Zhao CY, et al. TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy. PLoS One. 2014;9(5):e97985. https:\/\/doi.org\/10.1371\/journal.pone.0097985.","journal-title":"PLoS One"},{"issue":"1","key":"7540_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1681\/asn.2010111210","volume":"23","author":"M Lin","year":"2012","unstructured":"Lin M, Yiu WH, Wu HJ, et al. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol. 2012;23(1):86\u2013102. https:\/\/doi.org\/10.1681\/asn.2010111210.","journal-title":"J Am Soc Nephrol"},{"key":"7540_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1479-5876-8-133","volume":"8","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Peng T, Zhu H, et al. Prevention of hyperglycemia-induced myocardial apoptosis by gene silencing of toll-like receptor-4. J Transl Med. 2010;8:133. https:\/\/doi.org\/10.1186\/1479-5876-8-133.","journal-title":"J Transl Med"},{"issue":"10 Pt A","key":"7540_CR20","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.bbadis.2015.07.015","volume":"1852","author":"A Tao","year":"2015","unstructured":"Tao A, Song J, Lan T, et al. Cardiomyocyte-fibroblast interaction contributes to diabetic cardiomyopathy in mice: role of HMGB1\/TLR4\/IL-33 axis. Biochim Biophys Acta. 2015;1852(10 Pt A):2075\u201385. https:\/\/doi.org\/10.1016\/j.bbadis.2015.07.015.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"7540_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3724\/abbs.2023006","volume":"55","author":"J Wu","year":"2023","unstructured":"Wu J, Xiao D, Yu K, et al. The protective effect of the mitochondrial-derived peptide MOTS-c on LPS-induced septic cardiomyopathy. Acta Biochim Biophys Sin (Shanghai). 2023;55(2):285\u201394. https:\/\/doi.org\/10.3724\/abbs.2023006.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"7540_CR22","doi-asserted-by":"publisher","first-page":"175469","DOI":"10.1016\/j.ejphar.2022.175469","volume":"939","author":"J Jiang","year":"2023","unstructured":"Jiang J, Chang X, Nie Y, et al. Orally administered MOTS-c analogue ameliorates dextran sulfate sodium-induced colitis by inhibiting inflammation and apoptosis. Eur J Pharmacol. 2023;939:175469. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175469.","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"7540_CR23","doi-asserted-by":"publisher","first-page":"e20848","DOI":"10.1371\/journal.pone.0020848","volume":"6","author":"E Bess","year":"2011","unstructured":"Bess E, Fisslthaler B, Fr\u00f6mel T, Fleming I. Nitric oxide-induced activation of the AMP-activated protein kinase \u03b12 subunit attenuates I\u03baB kinase activity and inflammatory responses in endothelial cells. PLoS One. 2011;6(6):e20848. https:\/\/doi.org\/10.1371\/journal.pone.0020848.","journal-title":"PLoS One"},{"issue":"453","key":"7540_CR24","doi-asserted-by":"publisher","first-page":"ra109","DOI":"10.1126\/scisignal.aaf8566","volume":"9","author":"C Rutherford","year":"2016","unstructured":"Rutherford C, Speirs C, Williams JJ, et al. Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signaling. Sci Signal. 2016;9(453):ra109. https:\/\/doi.org\/10.1126\/scisignal.aaf8566.","journal-title":"Sci Signal"},{"issue":"13","key":"7540_CR25","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1161\/circulationaha.108.784298","volume":"118","author":"E Schulz","year":"2008","unstructured":"Schulz E, Dopheide J, Schuhmacher S, et al. Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction. Circulation. 2008;118(13):1347\u201357. https:\/\/doi.org\/10.1161\/circulationaha.108.784298.","journal-title":"Circulation"},{"key":"7540_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mce.2016.11.010","volume":"440","author":"SJ Mancini","year":"2017","unstructured":"Mancini SJ, White AD, Bijland S, et al. Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptor-associated kinase-4 phosphorylation. Mol Cell Endocrinol. 2017;440:44\u201356. https:\/\/doi.org\/10.1016\/j.mce.2016.11.010.","journal-title":"Mol Cell Endocrinol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-023-07540-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-023-07540-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-023-07540-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T05:21:59Z","timestamp":1748323319000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-023-07540-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,23]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["7540"],"URL":"https:\/\/doi.org\/10.1007\/s10557-023-07540-2","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,23]]},"assertion":[{"value":"12 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was conducted according to the \u201cGuide for the Care and Use of Laboratory Animals\u201d (NIH Publication No.85-23, revised in 2010). The animal experiments were approved by the Laboratory Animal Welfare and Ethics Committee of Renmin Hospital of Wuhan University (certificate No.2042019kf0074).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Authors give full consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}]}}